These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8603002)

  • 1. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group.
    Pulkki K; Pelliniemi TT; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
    Br J Haematol; 1996 Feb; 92(2):370-4. PubMed ID: 8603002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma.
    Kyrtsonis MC; Dedoussis G; Zervas C; Perifanis V; Baxevanis C; Stamatelou M; Maniatis A
    Br J Haematol; 1996 May; 93(2):398-400. PubMed ID: 8639436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity.
    Papadaki H; Kyriakou D; Foudoulakis A; Markidou F; Alexandrakis M; Eliopoulos GD
    Acta Haematol; 1997; 97(4):191-5. PubMed ID: 9158660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma.
    Stasi R; Brunetti M; Parma A; Di Giulio C; Terzoli E; Pagano A
    Cancer; 1998 May; 82(10):1860-6. PubMed ID: 9587117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of elevated soluble interleukin-6 receptor levels in the sera of patients with plasma cell dyscrasias.
    Ohtani K; Ninomiya H; Hasegawa Y; Kobayashi T; Kojima H; Nagasawa T; Abe T
    Br J Haematol; 1995 Sep; 91(1):116-20. PubMed ID: 7577617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Soluble interleukin-6 receptors in the serum in multiple myeloma].
    Scudla V; Kubalová D; Bacovský J; Lukes J; Vavrdová V
    Cas Lek Cesk; 1996 Nov; 135(22):719-22. PubMed ID: 8998823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in multiple myeloma.
    Kyle RA
    Stem Cells; 1995 Aug; 13 Suppl 2():56-63. PubMed ID: 8520513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors.
    Turesson I; Abildgaard N; Ahlgren T; Dahl I; Holmberg E; Hjorth M; Nielsen JL; Odén A; Seidel C; Waage A; Westin J; Wislöff F
    Br J Haematol; 1999 Sep; 106(4):1005-12. PubMed ID: 10520004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
    Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
    Transplantation; 1996 Jul; 62(1):138-42. PubMed ID: 8693533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field.
    Hisano S; Sakamoto K; Ishiko T; Kamohara H; Ogawa M
    Cytokine; 1997 Jun; 9(6):447-52. PubMed ID: 9199879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.
    Salvi M; Girasole G; Pedrazzoni M; Passeri M; Giuliani N; Minelli R; Braverman LE; Roti E
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2976-9. PubMed ID: 8768861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H; Robak E
    Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.
    Tsirakis G; Pappa CA; Kaparou M; Boula A; Katsomitrou V; Xekalou A; Kyriakaki S; Alexandrakis MG
    Tumour Biol; 2013 Apr; 34(2):859-64. PubMed ID: 23242610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble IL-6 receptor concentrations correlate with stages of multiple myeloma defined by serum beta 2-microglobulin and C-reactive protein.
    Kyriakou D; Papadaki H; Eliopoulos AG; Foudoulakis A; Alexandrakis M; Eliopoulos GD
    Int J Hematol; 1997 Oct; 66(3):367-71. PubMed ID: 9401283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
    Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
    J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Levels of Interleukin-8 and Soluble Interleukin-6 Receptor in Patients with Stage-I Multiple Myeloma: A Case-Control Study.
    Kohsari M; Khadem-Ansari MH; Rasmi Y; Sayyadi H
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):127-132. PubMed ID: 31983174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.